2023-504698-19-00招募中4 期
Bioequivalence of two transdermal therapeutic systems delivering 100 mcg/h fentanyl
CCDRD Cooperative Clinical Drug Research and Development AG, Lavipharm S.A.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年2月21日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Ligia Panaitescu
Scientific
Lavipharm S.A.
研究点 (1)
Loading locations...
相似试验
招募中
4 期
Bioequivalence of two transdermal therapeutic systems delivering 100 mcg/h fentanyl2024-517506-29-00CCDRD Cooperative Clinical Drug Research and Development AG, Lavipharm S.A.30
已完成
4 期
Bioequivalence clinical trial of two formulations of linagliptin/metformin2024-515076-13-00Laboratorios Normon S.A.48
已完成
4 期
Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin2023-507226-16-00Laboratorios Normon S.A.36
已完成
4 期
Bioequivalence clinical trial of two formulations of hydrochlorothiazide.2023-505692-72-00Laboratorios Normon S.A.30
已完成
1 期
Evaluation of the bioavailability of two transdermal gel preparations containing 0.1% w/w estradiol under fasting conditions: Estradiol/INTERMED gel 0.1% w/w (Test) vs. ESTREVA® 0.1%, gel (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy postmenopausal women2024-517969-16-00CCDRD Cooperative Clinical Drug Research and Development AG, Ioulia And Irene Tseti Pharmaceutical Laboratories S.A.18